Cargando…

Evaluation of pre-symptomatic nitisinone treatment on long-term outcomes in Tyrosinemia type 1 patients: a systematic review

BACKGROUND: Tyrosinemia type 1 (TYR1) is a rare autosomal recessive disorder of amino acid metabolism that is fatal without treatment. With medication (nitisinone) and dietary restrictions outcomes are improved. We conducted a systematic review to investigate if treatment with nitisinone following s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geppert, Julia, Stinton, Chris, Freeman, Karoline, Fraser, Hannah, Clarke, Aileen, Johnson, Samantha, Sutcliffe, Paul, Taylor-Phillips, Sian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594482/ https://www.ncbi.nlm.nih.gov/pubmed/28893311 http://dx.doi.org/10.1186/s13023-017-0696-z

Ejemplares similares

Newborn screening for Tyrosinemia type 1 using succinylacetone – a systematic review of test accuracy
por: Stinton, Chris, et al.
Publicado: (2017)

Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy
por: Freeman, Karoline, et al.
Publicado: (2021)

Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review
por: Fraser, Hannah, et al.
Publicado: (2019)

Newborn Screening for Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase and Mitochondrial Trifunctional Protein Deficiencies Using Acylcarnitines Measurement in Dried Blood Spots—A Systematic Review of Test Accuracy
por: Stinton, Chris, et al.
Publicado: (2021)

Neurological Crises after Discontinuation of Nitisinone (NTBC) Treatment in Tyrosinemia
por: HONAR, Naser, et al.
Publicado: (2017)

Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain
por: Couce, María Luz, et al.
Publicado: (2019)

Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
por: Das, Anibh Martin
Publicado: (2017)

Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuria
por: Hughes, Juliette H., et al.
Publicado: (2020)

Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet
por: García, María Ignacia, et al.
Publicado: (2017)

Adverse events in women and children who have received intrapartum antibiotic prophylaxis treatment: a systematic review
por: Seedat, Farah, et al.
Publicado: (2017)

Validation of a therapeutic range for nitisinone in patients treated for tyrosinemia type 1 based on reduction of succinylacetone excretion
por: Jack, Rhona M., et al.
Publicado: (2019)

Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype
por: Neuckermans, Jessie, et al.
Publicado: (2023)

Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation
por: Colemonts-Vroninks, Haaike, et al.
Publicado: (2020)

Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy
por: Freeman, Karoline, et al.
Publicado: (2019)

Short-term nitisinone discontinuation of hereditary tyrosinemia type 1 mice causes metabolic alterations in glutathione metabolism/biosynthesis and multiple amino acid degradation pathways
por: Haaike, Colemonts-Vroninks, et al.
Publicado: (2022)

Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis
por: Taylor-Phillips, Sian, et al.
Publicado: (2016)

Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients with Hereditary Tyrosinemia Type 1
por: Guffon, Nathalie, et al.
Publicado: (2017)

Where’s WALY? : A proof of concept study of the ‘wellbeing adjusted life year’ using secondary analysis of cross-sectional survey data
por: Johnson, Rebecca, et al.
Publicado: (2016)

Hepatorenal tyrosinemia
por: KITAGAWA, Teruo
Publicado: (2012)

Preventive use of nitisinone in alkaptonuria
por: Wolffenbuttel, Bruce H. R., et al.
Publicado: (2021)

Adequacy of nitisinone for the management of alkaptonuria
por: Abbas, Khawar, et al.
Publicado: (2022)

The Discovery of the Mode of Action of Nitisinone
por: Lock, Edward A.
Publicado: (2022)

Association between use of systematic reviews and national policy recommendations on screening newborn babies for rare diseases: systematic review and meta-analysis
por: Taylor-Phillips, Sian, et al.
Publicado: (2018)

Fatigue in radiology: a fertile area for future research
por: Taylor-Phillips, Sian, et al.
Publicado: (2019)

Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysis
por: Mottram, Rebecca, et al.
Publicado: (2021)

Test accuracy of faecal calprotectin for inflammatory bowel disease in UK primary care: a retrospective cohort study of the THIN data
por: Freeman, Karoline, et al.
Publicado: (2021)

Comparing outcomes from tailored meta-analysis with outcomes from a setting specific test accuracy study using routine data of faecal calprotectin testing for inflammatory bowel disease
por: Freeman, Karoline, et al.
Publicado: (2022)

Is monitoring of plasma 5-fluorouracil levels in metastatic / advanced colorectal cancer clinically effective? A systematic review
por: Freeman, Karoline, et al.
Publicado: (2016)

Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria
por: Ranganath, L. R., et al.
Publicado: (2022)

The incidence and prevalence of inflammatory bowel disease in UK primary care: a retrospective cohort study of the IQVIA Medical Research Database
por: Freeman, Karoline, et al.
Publicado: (2021)

Faecal calprotectin testing in UK general practice: a retrospective cohort study using The Health Improvement Network database
por: Freeman, Karoline, et al.
Publicado: (2021)

Total Hip Replacement for the Treatment of End Stage Arthritis of the Hip: A Systematic Review and Meta-Analysis
por: Tsertsvadze, Alexander, et al.
Publicado: (2014)

Syndrome of hereditary tyrosinemia in mink
por: Christensen, K, et al.
Publicado: (1978)

Test accuracy of drug and antibody assays for predicting response to antitumour necrosis factor treatment in Crohn’s disease: a systematic review and meta-analysis
por: Freeman, Karoline, et al.
Publicado: (2017)

Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone
por: Imrich, Richard, et al.
Publicado: (2022)

Electronic structure and molecular properties of nitisinone and mesotrione in water
por: Imrich, Richard, et al.
Publicado: (2023)

Comment on Pancreatitis in Type 1 Tyrosinemia
por: Rahmoune, Hakim, et al.
Publicado: (2017)

Tyrosinemia type III in an asymptomatic girl
por: Szymanska, Edyta, et al.
Publicado: (2015)

Long‐term low dose nitisinone therapy in adults with alkaptonuria shows no cognitive decline or increased severity of depression
por: Davison, Andrew S., et al.
Publicado: (2022)

A Stability Indicating HPLC Method for the Determination of Nitisinone in Capsules
por: Souri, Effat, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bj1gkdk8i6jtjim1ahsckvknhb